NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ModivCare, Inc. ("ModivCare" or "the Company") (NASDAQ:MODV). Investors who purchased ModivCare securities prior to November 3, 2022, and continue to hold to the present, are encouraged to obtain additional […]
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV). Investors who purchased Elevance securities prior to April 18, 2024, and continue to hold to the present, are encouraged to obtain
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Smartsheet Inc. ("Smartsheet" or the "Company") (NYSE:SMAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Varonis Systems, Inc. ("Varonis" or the "Company") (NASDAQ:VRNS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK, NY / ACCESS Newswire / February 1, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Jasper Therapeutics, Inc. ("Jasper" or "the Company") (NASDAQ:JSPR). Investors who purchased Jasper securities prior to November 30, 2023, and continue to hold to the present, are encouraged to obtain additional
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pacira BioSciences, Inc. ("Pacira" or "the Company") (NASDAQ:PCRX). Investors who purchased Pacira securities prior to August 2, 2023, and continue to hold to the present, are encouraged to obtain
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. ("Quantum" or the "Company") (NASDAQ:QNTM).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Quanex Building Products Corporation ("Quanex" or "the Company") (NYSE:NX). Investors who purchased Quanex securities prior to December 12, 2024, and continue to hold to the present, are encouraged to
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against BellRing Brands, Inc. ("BellRing" or the "Company") (NYSE:BRBR).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK, NY / ACCESS Newswire / February 1, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sun Communities, Inc. ("Sun Communities" or "the Company") (NYSE:SUI). Investors who purchased Sun Communities securities prior to February 28, 2019, and continue to hold to the present, are encouraged to